Daphne Taylor - 08 Aug 2023 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
SVP, CFO
Signature
/s/ SoYoung Kwon, Attorney-in-Fact
Issuer symbol
APVO
Transactions as of
08 Aug 2023
Net transactions value
$0
Form type
4
Filing time
10 Aug 2023, 08:47:11 UTC
Previous filing
07 Mar 2023
Next filing
30 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APVO Common Stock Options Exercise +6,945 +128% 12,368 08 Aug 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APVO Restricted Stock Unit Options Exercise $0 -6,945 -50% $0.000000 6,944 08 Aug 2023 Common Stock 6,945 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2 On August 9, 2022, the reporting person was granted 13,889 RSUs, vesting in two approximately equal installments beginning on August 8, 2023.